New Edge Advisors, LLC Cumberland Pharmaceuticals Inc Transaction History
New Edge Advisors, LLC
- $20.5 Billion
- Q3 2025
A detailed history of New Edge Advisors, LLC transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 756 shares of CPIX stock, worth $1,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
756
Previous 1,428
47.06%
Holding current value
$1,595
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CPIX
# of Institutions
33Shares Held
3.39MCall Options Held
24.7KPut Options Held
21.3K-
Israel Englander Millennium Management LLC | New York, Ny599KShares$1.26 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX556KShares$1.17 Million0.27% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny515KShares$1.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA412KShares$868,8680.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX281KShares$592,6330.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $30.9M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...